Aigbogun O - Search Results

1

Beyond Patient Characteristics: A Narrative Review of Contextual Factors Influencing Involuntary Admissions in Mental Health Care.

Aluh DO, Aigbogun O, Ukoha-Kalu BO, Silva M, Grigaitė U, Pedrosa B, Santos-Dias M, Cardoso G, Caldas-de-Almeida JM. Aluh DO, et al. Among authors: aigbogun o. Healthcare (Basel). 2023 Jul 9;11(14):1986. doi: 10.3390/healthcare11141986. Healthcare (Basel). 2023. PMID: 37510426 Free PMC article. Review.

2

Depression Among Immigrant Nigerians in Canada.

Aluh DO, Aigbogun O, Anyachebelu OC. Aluh DO, et al. Among authors: aigbogun o. J Immigr Minor Health. 2023 Apr;25(2):315-323. doi: 10.1007/s10903-022-01404-x. Epub 2022 Oct 21. J Immigr Minor Health. 2023. PMID: 36271302

3

Global pharma departure from Nigeria: A threat to public health.

Aluh DO, Aigbogun O, Okoro RN. Aluh DO, et al. Among authors: aigbogun o. J Med Access. 2024 May 23;8:27550834241256450. doi: 10.1177/27550834241256450. eCollection 2024 Jan-Dec. J Med Access. 2024. PMID: 38799086 Free PMC article. No abstract available.

4

Cross-sectional survey data on the socio-demographic characteristics associated with substance use among internal displaced persons in Maiduguri, Nigeria.

Aigbogun O, Aluh DO, Okoro RN, Yousefi M, Fawehinmi O, Abdullahi MS. Aigbogun O, et al. Data Brief. 2023 Nov 30;52:109875. doi: 10.1016/j.dib.2023.109875. eCollection 2024 Feb. Data Brief. 2023. PMID: 38146289 Free PMC article.

5

The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules.

Aigbogun OP, Phenix CP, Krol ES, Price EW. Aigbogun OP, et al. Mol Pharm. 2023 Feb 6;20(2):853-874. doi: 10.1021/acs.molpharmaceut.2c00821. Epub 2023 Jan 25. Mol Pharm. 2023. PMID: 36696533 Review.

6

An HPLC-UV validated bioanalytical method for measurement of in vitro phase 1 kinetics of α-synuclein binding bifunctional compounds.

Aigbogun OP, Nwabufo CK, Owens MN, Allen KJH, Lee JS, Phenix CP, Krol ES. Aigbogun OP, et al. Xenobiotica. 2022 Aug;52(8):916-927. doi: 10.1080/00498254.2022.2140315. Xenobiotica. 2022. PMID: 36282181

7

Potential application of mass spectrometry imaging in pharmacokinetic studies.

Nwabufo CK, Aigbogun OP. Nwabufo CK, et al. Among authors: aigbogun op. Xenobiotica. 2022 Aug;52(8):811-827. doi: 10.1080/00498254.2022.2119900. Xenobiotica. 2022. PMID: 36048000 Review.

8

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease.

Nwabufo CK, Aigbogun OP. Nwabufo CK, et al. Among authors: aigbogun op. J Neurol. 2022 Nov;269(11):5762-5786. doi: 10.1007/s00415-022-11267-9. Epub 2022 Jul 13. J Neurol. 2022. PMID: 35831620 Free PMC article. Review.

9

Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds.

Nwabufo CK, Aigbogun OP, Allen KJH, Owens MN, Lee JS, Phenix CP, Krol ES. Nwabufo CK, et al. Among authors: aigbogun op. Xenobiotica. 2021 Aug;51(8):885-900. doi: 10.1080/00498254.2021.1943566. Epub 2021 Jun 30. Xenobiotica. 2021. PMID: 34187286

10

Thermal sensation and the skin sensation test: regional differences and their effects on the issue of reliability of temperature ranges.

Odia GI, Aigbogun OS. Odia GI, et al. Among authors: aigbogun os. Aust J Physiother. 1988;34(2):89-93. doi: 10.1016/S0004-9514(14)60603-6. Aust J Physiother. 1988. PMID: 25026050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page